Testmate Health raises funding

Testmate Health develops rapid, single-use molecular tests to screen for chlamydia and gonorrhoea without a laboratory. The US hospital network Intermountain Health is becoming a shareholder, for an undisclosed amount, and will support clinical validation through to FDA approval.

Announced on
Round
Undisclosed round
Amount
Amount not disclosed
Location
canton of Vaud
Sector
Health & medtech

Investors

  • Intermountain Health

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic